Implementation of a lung cancer screening initiative in HIV-infected subjects.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 08 02 2021
accepted: 02 11 2021
entrez: 10 12 2021
pubmed: 11 12 2021
medline: 14 1 2022
Statut: epublish

Résumé

In this pilot program of low-dose computed tomography (LDCT) for the screening of lung cancer (LC) in a targeted population of people with HIV (PWH), its prevalence was 3.6%; the number needed to screen in order to detect one case of lung cancer was 28, clearly outweighing the risks associated with lung cancer screening. While data from additional cohorts with longitudinal measurements are needed, PWH are a target population for lung cancer screening with LDCT.

Identifiants

pubmed: 34890391
doi: 10.1371/journal.pone.0260069
pii: PONE-D-21-03298
pmc: PMC8664191
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0260069

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Oncol Res Treat. 2017;40(3):88-92
pubmed: 28259887
AIDS. 2014 Mar 27;28(6):881-90
pubmed: 24300545
Lancet Oncol. 2017 Dec;18(12):e754-e766
pubmed: 29208441
N Engl J Med. 2020 Feb 6;382(6):503-513
pubmed: 31995683
AIDS. 2016 Feb 20;30(4):573-82
pubmed: 26829006
N Engl J Med. 2009 Dec 3;361(23):2221-9
pubmed: 19955524
N Engl J Med. 2014 Nov 6;371(19):1793-802
pubmed: 25372087
HIV Med. 2017 Nov;18(10):787-789
pubmed: 28503852
BMC Cancer. 2017 Apr 14;17(1):270
pubmed: 28410587
Eur Respir J. 2013 Dec;42(6):1659-67
pubmed: 23845716
JAMA. 2012 Jun 13;307(22):2418-29
pubmed: 22610500
Ann Intern Med. 2014 Mar 4;160(5):330-8
pubmed: 24378917
Clin Infect Dis. 2019 Feb 1;68(4):650-657
pubmed: 29912335
Ann Intern Med. 2018 Jun 19;168(12):866-873
pubmed: 29801099
Womens Health (Lond). 2017 Dec;13(3):68-79
pubmed: 28952428
Ann Glob Health. 2019 Jan 22;85(1):
pubmed: 30741509
Am J Respir Crit Care Med. 2016 Mar 1;193(5):534-41
pubmed: 26502000
J Thorac Oncol. 2014 Jun;9(6):752-9
pubmed: 24828660
AIDS. 2017 Sep 10;31(14):1973-1977
pubmed: 28857778
Curr Opin HIV AIDS. 2017 Jan;12(1):31-38
pubmed: 27607596
AIDS. 2018 Jun 19;32(10):1333-1342
pubmed: 29683843
JAMA Oncol. 2021 May 1;7(5):684-686
pubmed: 33687430

Auteurs

Jorge Díaz-Álvarez (J)

Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, Facultad de Medicina, Universidad de Alcalá, IRYCIS, Madrid, Spain.

Patricia Roiz (P)

Department of Internal Medicine, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Department of Radiology, Hospital Universitario Ramón y Cajal, Madrid, Spain.

Luis Gorospe (L)

Department of Internal Medicine, Hospital de Ávila, Ávila, Spain.

Ana Ayala (A)

Department of Internal Medicine, Hospital de Ávila, Ávila, Spain.

Sergio Pérez-Pinto (S)

Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, Madrid, Spain.

Javier Martínez-Sanz (J)

Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, Facultad de Medicina, Universidad de Alcalá, IRYCIS, Madrid, Spain.

Matilde Sánchez-Conde (M)

Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, Facultad de Medicina, Universidad de Alcalá, IRYCIS, Madrid, Spain.

José L Casado (JL)

Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, Facultad de Medicina, Universidad de Alcalá, IRYCIS, Madrid, Spain.

María J Pérez-Elías (MJ)

Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, Facultad de Medicina, Universidad de Alcalá, IRYCIS, Madrid, Spain.

Ana Moreno (A)

Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, Facultad de Medicina, Universidad de Alcalá, IRYCIS, Madrid, Spain.

Raquel Ron (R)

Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, Facultad de Medicina, Universidad de Alcalá, IRYCIS, Madrid, Spain.

María J Vivancos (MJ)

Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, Facultad de Medicina, Universidad de Alcalá, IRYCIS, Madrid, Spain.

Pilar Vizcarra (P)

Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, Facultad de Medicina, Universidad de Alcalá, IRYCIS, Madrid, Spain.

Santiago Moreno (S)

Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, Facultad de Medicina, Universidad de Alcalá, IRYCIS, Madrid, Spain.

Sergio Serrano-Villar (S)

Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, Facultad de Medicina, Universidad de Alcalá, IRYCIS, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH